Ivermectin to Prevent SARS-CoV-2 (COVID-19) Hospitalisation in Subjects Over 50
Clinical trial NCT05993143 · TERMINATED
Trial details
- NCT number
- NCT05993143
- Sponsor
- Insud Pharma
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-18
- Primary completion
- 2021-07-21
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.